Desperate patients get early access to experimental muscle cell treatment
NCT ID NCT04661293
First seen Feb 16, 2026 · Last updated May 16, 2026 · Updated 14 times
Summary
This program provides early access to an experimental treatment using a patient's own muscle cells for serious or life-threatening diseases when no other options exist. Doctors can request the therapy for eligible patients, but it is not a cure and requires careful risk-benefit assessment. The goal is to control disease and improve quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new related studies are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cook MyoSite, Inc.
Pittsburgh, Pennsylvania, 15238, United States